![Sophie Pierrin-Lépinard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sophie Pierrin-Lépinard
Directeur/Membre du Conseil chez
ScreenCell SA
Profil
Sophie Pierrin-Lépinard was the founder of Banexi Ventures Partners SA, founded in 1998, where the title held was General Partner from 2011 to 2016.
Current jobs include Director at ScreenCell SA and Managing Partner at Kreaxi SASU since 2016.
Former jobs include Non-Executive Director at Antabio SAS, Director at Symetis SA, and Member-Management Board at Apoxis SA. Education includes a doctorate from Université Fédérale Toulouse Midi-Pyrénées and a graduate degree from ESCP Europe Campus Paris.
Postes actifs de Sophie Pierrin-Lépinard
| Sociétés | Poste | Début |
|---|---|---|
ScreenCell SA
 ScreenCell SA Miscellaneous Commercial ServicesCommercial Services Offers clinically confirmed solutions for the isolation of rare cells in the blood and other fluids | Directeur/Membre du Conseil | 17/02/2011 |
Kreaxi SASU
 Kreaxi SASU Investment ManagersFinance Kreaxi is an active manager which invests in French and European tech companies with sales up to EUR 100M. The firm invests in companies in the life sciences and information and communication technology sectors. Kreaxi manages various investment funds which invests from seed to later stage transactions. | Private Equity Investor | 01/11/2016 |
BNP Paribas Développement SA
 BNP Paribas Développement SA Investment ManagersFinance BNP Paribas Développement invests in SMEs and middle market companies located in France with revenues of EUR 10 - 100 million. The firm focuses on healthtech, digital health, deeptech, ecological transition and cybersecurity sectors. It provides financing for seed, early, growth and buyout stage capital requirements with an investment size of EUR 0.5 - 20 million. The firm also acts as a co-lead investor and makes follow on investments. It also acquires minority interests. | Private Equity Investor | 01/12/2017 |
Anciens postes connus de Sophie Pierrin-Lépinard
| Sociétés | Poste | Fin |
|---|---|---|
Banexi Ventures Partners SA
 Banexi Ventures Partners SA Investment ManagersFinance BVP is a venture capital investment firm focused on European emerging and early-stage companies based on high technology and with high-growth potential. The firm may also invest marginally in later-stage operations such as corporate spin offs, turnarounds and special situations. BVP specializes in sectors related to information technology, Internet and infomedia, mobile applications, electronics, semiconductors, optics and life sciences. The firm seeks to identify management teams with a demonstrated ability to manage rapid growth. Investment decisions are based on a due diligence process assessing technology distinctiveness, intellectual property protection, products, markets and competitive advantages. The firm invests either on their own or in syndication, and acquires majority or significant minority stakes. | Fondateur | 16/11/2016 |
Apoxis SA
 Apoxis SA Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer | Corporate Officer/Principal | 01/08/2007 |
Antabio SAS
 Antabio SAS Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs | Directeur/Membre du Conseil | - |
| SYMETIS SA | Directeur/Membre du Conseil | - |
Formation de Sophie Pierrin-Lépinard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
BNP Paribas Développement SA
BNP Paribas Développement SA Investment ManagersFinance BNP Paribas Développement invests in SMEs and middle market companies located in France with revenues of EUR 10 - 100 million. The firm focuses on healthtech, digital health, deeptech, ecological transition and cybersecurity sectors. It provides financing for seed, early, growth and buyout stage capital requirements with an investment size of EUR 0.5 - 20 million. The firm also acts as a co-lead investor and makes follow on investments. It also acquires minority interests. | Finance |
Apoxis SA
Apoxis SA Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of cancer | Health Technology |
Banexi Ventures Partners SA
Banexi Ventures Partners SA Investment ManagersFinance BVP is a venture capital investment firm focused on European emerging and early-stage companies based on high technology and with high-growth potential. The firm may also invest marginally in later-stage operations such as corporate spin offs, turnarounds and special situations. BVP specializes in sectors related to information technology, Internet and infomedia, mobile applications, electronics, semiconductors, optics and life sciences. The firm seeks to identify management teams with a demonstrated ability to manage rapid growth. Investment decisions are based on a due diligence process assessing technology distinctiveness, intellectual property protection, products, markets and competitive advantages. The firm invests either on their own or in syndication, and acquires majority or significant minority stakes. | Finance |
Symetis SA
 Symetis SA BiotechnologyHealth Technology Develops products for pediatric cardio-vascular applications | Health Technology |
Université Fédérale Toulouse Midi-Pyrénées
 Université Fédérale Toulouse Midi-Pyrénées Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ESCP Europe Campus Paris
 ESCP Europe Campus Paris Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
ScreenCell SA
ScreenCell SA Miscellaneous Commercial ServicesCommercial Services Offers clinically confirmed solutions for the isolation of rare cells in the blood and other fluids | Commercial Services |
Antabio SAS
Antabio SAS Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical drugs | Health Technology |
Kreaxi SASU
Kreaxi SASU Investment ManagersFinance Kreaxi is an active manager which invests in French and European tech companies with sales up to EUR 100M. The firm invests in companies in the life sciences and information and communication technology sectors. Kreaxi manages various investment funds which invests from seed to later stage transactions. | Finance |
